Cyclacel Pharmaceuticals Q1 EPS $(0.04) Up From $(11.52) YoY, Sales $778.000K

Benzinga Newsdesk www.benzinga.com Negative 60.0%

Neg 60% Neu 0% Pos 0%

Cyclacel Pharmaceuticals (NASDAQ:BGMS) reported quarterly losses of $(0.04) per share. This is a 99.65 percent increase over losses of $(11.52) per share from the same period last year. The company reported $778.000 thousand in sales this quarter.